CareDx, Inc. (CDNA)
NASDAQ: CDNA · Real-Time Price · USD
80.72
-3.70 (-4.38%)
Nov 10, 2026, 3:15 PM EST - Market open
CareDx Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 497.4 | 379.81 | 333.79 | 280.32 | 321.79 | 296.4 | |
Revenue Growth | 38.94% | 13.79% | 19.07% | -12.89% | 8.57% | 54.22% |
Cost of Revenue | 144.39 | 123.24 | 109.7 | 102.07 | 112.21 | 97.39 |
Gross Profit | 353 | 256.57 | 224.09 | 178.26 | 209.58 | 199.01 |
Selling, General & Admin | 260.75 | 207.95 | 207.11 | 202.9 | 196.42 | 152.21 |
Research & Development | 84.42 | 71.43 | 72.51 | 82.42 | 90.39 | 76.53 |
Operating Expenses | 345.18 | 279.38 | 279.62 | 285.32 | 286.81 | 228.73 |
Operating Income | 7.83 | -22.81 | -55.54 | -107.06 | -77.23 | -29.73 |
Interest & Investment Income | 9.14 | 10.45 | 12.39 | 6.66 | 4.15 | 1.29 |
Other Non Operating Income (Expenses) | -0.13 | 0.52 | 0.33 | 1.35 | -2.77 | -0.78 |
EBT Excluding Unusual Items | 16.83 | -11.84 | -42.82 | -99.05 | -75.84 | -29.22 |
Merger & Restructuring Charges | -3.7 | - | - | - | - | - |
Gain (Loss) on Sale of Investments | -1.27 | -1.27 | -0.62 | 5.21 | -0.39 | -2.87 |
Asset Writedown | - | -2.26 | - | - | - | - |
Legal Settlements | -0.6 | -5.71 | 96.3 | -96.3 | - | - |
Pretax Income | 124.22 | -21.08 | 52.86 | -190.14 | -76.23 | -32.09 |
Income Tax Expense | -4.41 | 0.27 | 0.31 | 0.14 | 0.38 | -1.43 |
Earnings From Continuing Operations | 128.63 | -21.35 | 52.55 | -190.28 | -76.61 | -30.66 |
Net Income | 128.63 | -21.35 | 52.55 | -190.28 | -76.61 | -30.66 |
Net Income to Common | 128.63 | -21.35 | 52.55 | -190.28 | -76.61 | -30.66 |
Net Income Growth | 82.58% | - | - | - | - | - |
Shares Outstanding (Basic) | 51 | 53 | 53 | 54 | 53 | 52 |
Shares Outstanding (Diluted) | 53 | 53 | 57 | 54 | 53 | 52 |
Shares Change | -7.68% | -5.89% | 5.31% | 0.83% | 2.07% | 12.39% |
EPS (Basic) | 2.50 | -0.40 | 1.00 | -3.54 | -1.44 | -0.59 |
EPS (Diluted) | 2.41 | -0.40 | 0.93 | -3.54 | -1.44 | -0.59 |
EPS Growth | 98.43% | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 59.76 | 36.12 | 31.56 | -26.73 | -46.47 | -32.85 |
Free Cash Flow Per Share | 1.12 | 0.68 | 0.56 | -0.50 | -0.87 | -0.63 |
Gross Margin | 70.97% | 67.55% | 67.14% | 63.59% | 65.13% | 67.14% |
Operating Margin | 1.57% | -6.01% | -16.64% | -38.19% | -24.00% | -10.03% |
Profit Margin | 25.86% | -5.62% | 15.74% | -67.88% | -23.81% | -10.35% |
Free Cash Flow Margin | 12.01% | 9.51% | 9.46% | -9.54% | -14.44% | -11.08% |
EBITDA | 25.62 | -7.8 | -41.34 | -92.68 | -65.64 | -20.93 |
EBITDA Margin | 5.15% | -2.05% | -12.38% | -33.06% | -20.40% | -7.06% |
D&A For EBITDA | 17.8 | 15.02 | 14.19 | 14.39 | 11.6 | 8.8 |
EBIT | 7.83 | -22.81 | -55.54 | -107.06 | -77.23 | -29.73 |
EBIT Margin | 1.57% | -6.01% | -16.64% | -38.19% | -24.00% | -10.03% |
Effective Tax Rate | - | - | 0.59% | - | - | - |
Revenue as Reported | 497.4 | 379.81 | 333.79 | 280.32 | 321.79 | 296.4 |